miR-367 promotes tumor growth by inhibiting FBXW7 in NSCLC.
Xiao G, Gao X, Sun X, Yang C, Zhang B, Sun R, Huang G, Li X, Liu J, Du N, Liu D, Liang R, Ren H, Qin S.
Xiao G, et al.
Oncol Rep. 2017 Aug;38(2):1190-1198. doi: 10.3892/or.2017.5755. Epub 2017 Jun 27.
Oncol Rep. 2017.
PMID: 28656290